The treatment of ApoE knockout mice with recombinant IL-12 aggravated atherosclerosis progression, and higher plasma IL-12 levels were also confirmed as a biomarker in CAD patients [4], [31]. The gene discussed is APOE; the disease is atherosclerosis.